Is Recursion Pharmaceuticals a Meme Stock?

Is that the case? Let's look into it and decide whether the company is worth investing in.

Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery Leader?

Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

Recursion’s Incoming CEO Needs To Prove That AI Drug Development Can Pay Off

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.
IEEE

ADC: Enhancing Function Calling Via Adversarial Datasets and Code Line-Level Feedback

Abstract: Large Language Models (LLMs) have made significant strides in Natural Language Processing and coding, yet they struggle with robustness and accuracy in complex function calls. To tackle ...